HTTP/1.0 200 OK Content-Type: text/html
Pubdate: Mon, 11 Feb 2008 Source: Montreal Gazette (CN QU) Copyright: 2008 The Gazette, a division of Southam Inc. Contact: http://www.canada.com/montreal/montrealgazette/ Details: http://www.mapinc.org/media/274 Author: Peggy Curran A LITTLE SCIENCE WITH YOUR CAFE, MADAME? The patient is miserable, depressed, unable to work or cope with daily chores. Though his pain is chronic, intense and persistent, his family doctor refuses to prescribe heavy-duty narcotics, afraid they could prove to be addictive, or open to abuse, sold on the street to anyone desperate for a cheap fix. Only what's a physician to do when a drug like oxycodone, a synthetic opiate which has been dubbed "hillbilly heroin" for its reputation as the crack cocaine of rural Appalachia, really is the only treatment that will do the trick? For Mark Ware, associate medical director of the pain clinic at the McGill University Health Centre, it's the kind of complex and provocative question crying out for discussion - by medical professionals and the people who turn up in their waiting rooms pleading for relief. "These are issues we are struggling with," said Ware, whose own research explores the potential risks and benefits of cannabis use by patients who suffer from chronic pain. "The concerns of a mother worrying about possible abuse of the drug by her 15-year-old son may be very different from those of the sister of a 46-year-old breast cancer patient suffering the effects of chemotherapy." Tomorrow night, Montrealers will get a chance to share their thoughts and concerns at a Cafe Scientifique, an informal gathering where members of the public can chat with leading researchers in a setting that is less intimidating than a classroom or a doctor's office. A twist on the salons of 19th-century Paris, where intellectuals gathered to ponder life's big questions, cafes scientifiques resurfaced in Britain and France a decade ago. Rapidly gaining ground on this side of the Atlantic, they aim to broaden general knowledge of science and technology by demystifying complex concepts and getting people talking. Indeed, discussion leaders are cautioned not to hog the floor, rely on a PowerPoint presentation or do anything else that might scare - or bore - the civilians in their midst. The Canadian Institutes for Health Research kicked off its Science on Tap series last month at the Segafredo Zanetti cafe downtown with a discussion on infectious disease. This week's session, in partnership with McGill University, the MUHC, the Montreal Neurological Institute and the Douglas Mental Health University Institute, will focus on how drugs interact inside our brains, for better or worse. Remi Quirion, scientific director at the Douglas, will moderate the bilingual discussion, and Ware will be joined by addiction researchers Alain Dagher of the MNI and Marco Leyton from the MUHC. "It's a way to popularize some of the work that researchers are doing, by taking it from the ivory tower to the streets - or the pub, in this case," said Ware, who welcomes the opportunity for outreach, and to hear a multitude of opinions. Ware said physicians at the pain clinic sometimes have more time than your average overworked GP to talk with patients and figure out the right combination of medication and behavioural therapy that will ease their distress. He's not the least bit worried that audience members will be shy about speaking their minds. "I've seen people stand up and describe their pain in graphic detail in a room full of 400 people." The CIHR Cafe Scientifique's "Drugs: the Good, the Bad and the Useful" takes place tomorrow at 6 p.m. at O Patro Vys, 356 Mount Royal Ave. E. (corner St. Denis St.). Admission is free. - --- MAP posted-by: Derek